Telix Pharmaceuticals Limited: Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today provides a precision medicine portfolio update in relation ...

Nokian Tyres plc: The Nokian Tyres Romania factory reaches the target of one million tires in 2025

Nokian Tyres plc Press Release December 22, 2025, at 10:00 a.m. EET The Nokian Tyres factory in Oradea, Romania has produced its one millionth tire of the year on December 20th. The tire was produced ...

Skanska AB: Skanska divests two office buildings in Copenhagen, Denmark, for DKK 1.0 billion, about SEK 1.5 billion

Skanska has divested two fully leased office buildings in Ørestad City in Copenhagen, Denmark, for about DKK 1.0 billion, about SEK 1.5 billion. The buyer is PensionDanmark. The transaction will be re ...

Urbo Bankas: Report on the audited financial performance of the bank during the nine month of 2025

Urbo bankas UAB (hereinafter - "the Bank"), company code 112027077, address: Konstitucijos pr.18B, Vilnius. In the first three quarters of this year, Lithuania-based Urbo Bankas recorded double-digit ...

Skanska AB: Skanska widens expressway in San Jacinto, California, USA, for USD 107M, about SEK 1.1 billion

Skanska has signed a contract with the Riverside County Transportation Commission for the Mid County Parkway Ramona Expressway project in San Jacinto, California, USA. The contract is worth USD 107M, ...

Minesto AB: Minesto's Board of Directors dismisses claim for damages received from former major shareholder BGA Invest

Minesto AB ("Minesto" or the "Company") announces that the Company's Board of Directors dismisses a claim for damages directed against them from the former major shareholder BGA Invest AB ("BGA") as ...

Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply network Additional investments planned to expand the site's capacity (currently ...

Homeland Uranium Corp.: Homeland Confirms Southward Continuity of Anomalous Radioactivity at the Coyote Basin Uranium Project

Homeland Uranium Corp. (TSXV: HLU) (OTCQB: HLUCF) (FSE: D3U) ("Homeland" or the "Company") is pleased to provide a second update ...

Irisity AB: Stockhorn has announced that the mandatory public cash offer has been declared unconditional and that the acceptance period has been shortened

Stockhorn Capital AB ("Stockhorn") has announced that its mandatory public cash offer to the shareholders of Irisity AB (publ) ("Irisity" or the "Company") has been declared unconditional and that the ...

Rocket Lab Corporation: Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission Success

Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today successfully launched ...

Intrum: Intrum recognises impairment of SEK 3.4bn

Intrum AB (publ) ("Intrum") today announces that, following its annual impairment process and in accordance with IFRS, it will record a non-cash impairment charge of around SEK 3.4 billion in the four ...

AstraZeneca PLC: Enhertu granted BTD for post-neoadjuvant early BC

December 2025 Enhertu granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer Tenth Breakthrough Therapy Designation for Astr ...